MoonLake Immunotherapeutics (MLTX) Form 8-K — Jun 25, 2026
MoonLake Immunotherapeutics entered into an underwriting agreement to sell 9,000,000 Class A ordinary shares at a public offering price of $20.00 per share. In addition, the company will issue 1,000,000 pre-funded warrants to certain investors at a price of $19.9999 per warrant, which are exercisable immediately at $0.0001 per share. The gross proceeds from the offering are expected to be $200 million before deducting underwriting discounts and offering expenses. The underwriters have been granted a 30-day option to purchase up to an additional 1,500,000 ordinary shares at the public offering price, less underwriting discounts.
Key figures
- Gross Proceeds
- $200 million
- Offering Price
- $20.00
- Shares Offered
- 9,000,000
- Greenshoe Shares
- 1,500,000
- Pre Funded Warrants
- 1,000,000
- Warrant Exercise Price
- $0.0001
- Pre Funded Warrant Price
- $19.9999
Price after filing
Close on the filing date to close N calendar days later (from $19.99). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.